Studies in experimental systems have identified a multitude of mutational mechanisms including DNA replication infidelity and DNA damage followed by inefficient repair or replicative bypass. However, the relative contributions of these mechanisms to human germline mutation remain unknown. Here, we show that error-prone damage bypass on the lagging strand plays a major role in human mutagenesis. Transcription-coupled DNA repair removes lesions on the transcribed strand; lesions on the non-transcribed strand are preferentially converted into mutations. In human polymorphism we detect a striking similarity between mutation types predominant on the non-transcribed strand and on the strand lagging during replication. Moreover, damage-induced mutations in cancers accumulate asymmetrically with respect to the direction of replication, suggesting that DNA lesions are resolved asymmetrically. We experimentally demonstrate that replication delay greatly attenuates the mutagenic effect of ultraviolet irradiation, confirming that replication converts DNA damage into mutations. We estimate that at least 10% of human mutations arise due to DNA damage.
Studies in experimental systems have identified a multitude of mutational mechanisms including DNA replication infidelity and DNA damage followed by inefficient repair or replicative bypass. However, the relative contributions of these mechanisms to human germline mutation remain unknown. Here, we show that error-prone damage bypass on the lagging strand plays a major role in human mutagenesis. Transcription-coupled DNA repair removes lesions on the transcribed strand; lesions on the non-transcribed strand are preferentially converted into mutations. In human polymorphism we detect a striking similarity between mutation types predominant on the non-transcribed strand and on the strand lagging during replication. Moreover, damage-induced mutations in cancers accumulate asymmetrically with respect to the direction of replication, suggesting that DNA lesions are resolved asymmetrically. We experimentally demonstrate that replication delay greatly attenuates the mutagenic effect of ultraviolet irradiation, confirming that replication converts DNA damage into mutations. We estimate that at least 10% of human mutations arise due to DNA damage.
Experiments in model organisms have uncovered that DNA polymerases make errors and resulting mismatches become mutations 1 . An alternative mechanism of mutagenesis due to mis-repaired DNA damage or damage bypassed by translesion polymerases has been extensively studied in experimental systems exposed to exogenous mutagens 2, 3 . Although these studies shed light on the mechanistic details of mutagenesis, experimental systems provide little information on the relative contributions of these mechanisms to naturally occurring human mutations. Recently, computational genomics approaches have revealed statistical properties of mutations occurring in the germline [4] [5] [6] [7] , in tumors 8 and in embryo during early stages of development [9] [10] [11] . In cancer, many types of mutations have been successfully attributed to the action of specific mutagens 12 . A number of studies have explored how cancer mutations scale with age at diagnosis 13, 14 and how human germline mutations scale with paternal age [15] [16] [17] . It was hypothesized that the dependency of the number of accumulated mutations on the number of cell divisions may reflect the replicative origin of mutations 18, 19 . However, a quantitative model suggests that accumulation of both damage-induced and co-replicative mutations may scale with the number of cell divisions 20 . Therefore, we still do not know whether DNA damage substantially contributes to human mutations or whether they mostly arise due to errors in replication.
To discriminate between co-replicative mutations and damageinduced mutations, we rely on statistical properties of mutations unequivocally associated with DNA damage. Both germline and cancer mutations leave footprints in the form of mutational asymmetry with respect to the direction of transcription (T-asymmetry). T-asymmetry reflects the prevalence of mutations that originate from lesions on the non-transcribed strand that could not be repaired by transcription-coupled nucleotide excision repair (TC-NER) 21, 22 . Thus, the analysis of T-asymmetry may be used to quantify mutations arising from DNA lesions. Genomic data on cancers in which most mutations are caused by specific, well-understood, damageinducing agents provide an additional perspective on properties of damage-induced mutations. Notably, the level of T-asymmetry in these cancers is exceptionally high.
The most obvious statistical feature associated with replication is asymmetry with respect to the direction of the replication fork (R-asymmetry). R-asymmetry may reflect differential fidelity of replication between the leading and lagging strands. Alternatively, R-asymmetry may be caused by the strand-specific bypass of DNA damage. Bulky DNA lesions not repaired prior to replication can either lead to fork regression followed by error-free repair or be bypassed by translesion polymerases [23] [24] [25] . Translesion DNA synthesis does not remove the lesion and commonly introduces mutations on the newly synthesized strand. It has been asserted that the errorprone bypass process has different properties on leading and lagging strands 23, 26 that would lead to R-asymmetry.
As a starting point, we compare R-asymmetry with T-asymmetry. To avoid the interference of statistical signals between the two types of asymmetries, R-asymmetry is estimated exclusively in intergenic regions and T-asymmetry only in genic regions. We calculate R-asymmetries for the 92 types of single-nucleotide mutations in each trinucleotide context. CpG> TpG mutations are excluded because they usually arise via conversion of methylated cytosines directly into thymines by deamination 27 (Supplementary Note 1). Figure 1 shows data for rare (allele frequency < 0.1%) SNPs from the 
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Genome Aggregation Database (gnomAD) dataset 28 . Supplementary  Fig. 1 shows that R-asymmetries across different contexts are concordant between rare SNPs and de novo mutations.
Strikingly, there is a high concordance between T-asymmetry and R-asymmetry across mutation types in both tri-and pentanucleotide contexts ( Fig. 1 and Supplementary Fig. 2 ). Mutation types that are predominant on the lagging strand are also more common on the non-transcribed strand ( Fig. 1a ; R 2 = 0.84; P = 5.6 × 10 −37 ). This association holds even for six basic mutation classes separately ( Fig. 1b) .
T-asymmetry arises from mutations induced by DNA damage on the non-transcribed strand that is invisible to TC-NER repair 6 . As a result, the level of T-asymmetry scales with the proportion of damage-induced mutations. Figure 1 suggests that R-asymmetry 
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NATure GeNeTIcS may be due to similarly differential resolution of DNA damage between leading and lagging strands. DNA lesions on the lagging strand would be more frequently converted into mutations, probably due to error-prone damage bypass.
To pursue this hypothesis, we analyzed R-asymmetry in genomes of cancers exposed to specific mutagens. Four cancer types in Pan-Cancer Analysis of Whole Genomes (PCAWG) datasets contain samples with high levels of T-asymmetry in specific mutation contexts: melanoma, predominated by ultraviolet-induced C> T mutations (Catalogue of Somatic Mutations in Cancer (COSMIC) signature 7) 8 ; two lung cancers (lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC)), predominated by smoking-induced G> T mutations (signature 4); and liver cancer, with a high prevalence of A> G mutations (signatures 12 and 16). All of these processes reflect the action of DNA-damaging mutagens. About 95% of these samples demonstrate a weak but usually significant excess of mutations on the lagging strand ( Fig. 2 and Supplementary  Table 1 ). The mutagens acting primarily outside of replication also cause R-asymmetry, strongly suggesting that error-prone bypass on the lagging strand happens frequently. Levels of T-asymmetry and R-asymmetry are correlated across samples in lung and liver cancers ( Supplementary Fig. 3 ). Melanoma is the exception, possibly because variation in T-asymmetry across samples is primarily due to variation in TC-NER activity rather than damage intensity 
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( Supplementary Fig. 3) . A recent study also found an excess of damage-induced mutations corresponding to COSMIC signatures 23 (unknown etiology) and 24 (aflatoxin) on the lagging strand 29 . Consistent with our interpretation, tumor samples analyzed here that lack lacking damage-induced signatures do not exhibit a lagging strand bias (Supplementary Table 2 ).
The observed R-asymmetry is limited to samples with signatures of bulky damage rather than any type of damage. Tumors with MUTYH deficiency have a high load of mutations from oxoguanine lesions that do not block progression of RNA and DNA polymerases. Neither T-asymmetry nor R-asymmetry is detectable in these samples ( Supplementary Fig. 4 ). In contrast, R-asymmetry is significantly enhanced in cutaneous squamous cell carcinoma tumors from patients with congenital XPC deficiency (xeroderma pigmentosum) 30 . These tumors lack the global genome nucleotide excision repair (GG-NER) activity and have elevated levels of bulky damage (see Supplementary Note 2 and Supplementary Fig. 5 ).
If DNA lesions are more frequently bypassed by translesion DNA synthesis on the lagging strand directly across the lesion, they will persist on this strand through replication. Therefore, mutational asymmetry caused by the bypass in turn causes the asymmetry of unrepaired DNA damage. We utilize time series excision repair sequencing (XR-seq) data 31 to test whether the activity of the NER system is biased with respect to the replication fork direction. Indeed, repair is more frequently observed on the lagging strand ( Fig. 3) . Moreover, the difference between leading and lagging strands sharply increases with time after ultraviolet irradiation as more and more cells complete a round of replication.
To test whether the differential activity of the NER system reflects the preferential bypass of DNA damage, we analyzed the damage sequencing (Damage-seq) dataset 32 . Damage-seq was used to detect DNA damage (cyclobutane pyrimidine dimers (CPDs)) over a series of time points following the exposure of fibroblasts to ultraviolet radiation. The data show a clear dependency on transcription and preferential retention of damage on the non-transcribed strand ( Supplementary Fig. 6 ). A lagging strand bias of DNA damage progressively increases with time, mirroring the trend in XR-seq data ( Fig. 3) .
Collectively, the above observations support the differential replication bypass hypothesis, suggesting that many damage-induced mutations do not arise from mis-repair; instead, bulky lesions are converted to mutations during replication. Thus, replication delay should reduce mutation rate in cells exposed to damaging agents, because it would provide more time for cells to complete repair. To test this directly, we compared ultraviolet-irradiated fibroblasts exposed and not exposed to roscovitine, which reversibly arrests replication ( Fig. 4 ). Colonies grown from fibroblasts not treated with the chemical have ~14,000 mutations with spectra matching the ultraviolet signature ( Fig. 5 ). These mutations demonstrated both T-asymmetry and R-asymmetry quantitatively similar to cancer data (log 2 [T-asymmetry] = 0.50; log 2 [R-asymmetry] = 0.17; P < 0.01 for both). In sharp contrast, colonies derived from ultraviolet-irradiated cells that experienced replication delay (51 h of roscovitine treatment) possessed just ~2,000 mutations with no evident ultraviolet signature. Control cells that were treated by roscovitine but not exposed to ultraviolet irradiation have a highly similar spectrum of mutations and only ~400 fewer mutations. Therefore, replication delay decreased ultraviolet-induced mutation load by more than 30-fold. This provides strong support for error-prone replication bypass of bulky lesions being the major source of mutations, at least in our experimental system. Interestingly, it also suggests that mutations in melanoma primarily accumulate in dividing cells.
R-asymmetry not related to error-prone bypass was previously detected in several cancers and in experimental systems. It was attributed to differences in fidelity between polymerase ε and polymerase δ 1 (refs [33] [34] [35] ), or differential efficiency of mismatch repair between leading and lagging strands [33] [34] [35] [36] . APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) deaminates cytosines on the lagging strand 33, 35, 37, 38 , and mis-incorporation of oxo-guanine in esophageal cancer is highly asymmetric 39 . However, these processes neither match patterns observed for human germline mutations nor explain the strong association between R-and T-asymmetries and experimental data on ultraviolet-irradiated cells. A mechanism alternative to error-prone bypass may be responsible for R-asymmetry of CpG> TpG mutations in the human germline that are not caused by bulky lesions ( Supplementary Fig. 7 and Supplementary Note 1).
One possible alternative explanation for the similarity between R-asymmetry and T-asymmetry involves the exposure of DNA to a single-stranded conformation (ssDNA): the lagging strand stays in the single-stranded state during replication for a longer period, while the non-transcribed strand may occasionally adopt the single-stranded state because of R-loop formation 40, 41 . We have tested the effect of R-loops on T-asymmetry and found that, in the germline, the asymmetry does not increase in regions prone to R-loops compared with flanking regions within the same transcript ( Supplementary Fig. 8a ). Additional clues to the role of ssDNA may be provided by APOBEC-induced mutations because such mutations have a strong affinity for ssDNA 42, 43 . Again, we did not find that R-loops substantially affect the distribution of APOBECinduced mutations in cancers ( Supplementary Fig. 8b ). Hence, it is unlikely that ssDNA is the cause of T-asymmetry and of the association between T-asymmetry and R-asymmetry.
Taken together, the observed mutation patterns in the germline and in cancer, XR-seq and Damage-seq data and our experiments point to differential damage bypass as a likely source of R-asymmetry. This suggests that DNA damage substantially contributes to spontaneous mutations. T-asymmetry allows us to conservatively quantify its contribution. Assuming that DNA damage is uniform and that TC-NER is completely error free and is the only cause of the T-asymmetry (see Online Methods), we computed the minimal fraction of damage-induced mutations in highly transcribed genes. 
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Extrapolation of this estimate to the whole genome suggests that 10% of human germline mutations, 51-52% of mutations in melanoma, 40-44% of mutations in lung cancer and 25-27% of mutations in liver cancer are due to DNA damage. The estimates are high for cancers affected by known mutagens, albeit still lower than existing estimates 8 , attesting to the conservative nature of our analysis. From the biochemical perspective, a higher conversion rate of damage due to mutations on the lagging strand is unsurprising, as replication of the leading strand is less tolerant to damage. Helicase is attached to the leading strand and is therefore more sensitive to damage on this strand 23, 26 . Damage on the leading strand blocks polymerase ε , potentially causing fork uncoupling and stalling. This, in turn, may cause fork regression with lesion repair, template switch or homologous repair 23 ; all these processes are error free. With the exception of break-induced replication producing highly complex mutations, fork stalling is usually resolved by error-free mechanisms. Meanwhile, lesions on the lagging strand are unlikely to cause fork stalling and instead often result in only a short gap downstream from the lesion 23, 26 . Consequently, damage on the lagging strand is rarely removed during replication and is instead simply bypassed by error-prone mechanisms (translesion DNA synthesis). Our results corroborate earlier findings in the yeast system, where as many as 90% of spontaneous mutations have been attributed to translesion DNA synthesis through DNA lesions 44, 45 .
Our experimental results show that the number of damageinduced mutations reduces with the increasing time span between introduction of DNA damage and cell division. The computational analysis suggests that mutations statistically associated with replication do not necessarily arise as a result of replication errors alone. Earlier studies have demonstrated the dependency of the number of accumulated mutations on the number of cell divisions 46 . In line with theoretical models, the mutation rate scaling with the number of replications does not establish the mechanistic origin of mutations 20 .
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Methods Human polymorphism and cancer mutation data. To analyze mutational patterns reflected in human DNA polymorphism, we extracted SNPs with derived allele frequency < 0.1% from gnomAD data 28 . Cancer somatic mutations were extracted from PCAWG datasets 47 . Cancer somatic mutations identified in wild-type XPC and XPC −/− skin squamous cell carcinoma samples were downloaded from the Database of Genotypes and Phenotypes (dbGap; study accession phs000830). Samples with MUTYH deficiency where chosen according to annotation from Scarpa et al. 48 .
Experimental data on DNA damage and repair. The XR-seq dataset for CPDs reported by Adar et al. 31 allowed us to estimate the amount of DNA damage actively repaired by NER following ultraviolet irradiation. To directly assess the presence of unrepaired DNA damage, we used the Damage-seq data for CPDs provided by Hu et al. 32 We did not use XR-seq and Damage-seq data for pyrimidine-pyrimidone (6-4) photoproducts because these lesions are repaired too quickly to permit an accurate analysis of the effect of damage bypass over successive rounds of replication.
R-asymmetry. As described previously 37 , the 'derivative' (normalized rate of change) of replication timing may serve as a predictor of the preferential replication fork direction. This approach was proposed by Chen et al. 5 and has been used in recent cancer genomics studies 33, 35 . We focused on genomic regions showing a strong preference for a specific fork direction as evident from the replication timing 'derivative' . For the analysis of XR-seq and Damage-seq (Figs. 1a,b and 3a,b ), we used a conservative threshold corresponding to 10% of genomic regions with the highest absolute values of the replication timing 'derivative' . However, this threshold appeared too restrictive for cancer genome analyses, because many individual tumors have insufficient numbers of mutations within that 10% of the genome, so we relaxed the threshold to 40% for these analyses. Both of these thresholds have been used in previous studies 7, 33 , and the results have generally been robust with respect to the threshold chosen.
For each individual analysis, we selected the most relevant available replication timing dataset: IMR-90 cells for lung cancers, HepG2 cells for liver cancer and NHEK cells for melanoma and squamous cell carcinoma. For germline mutations, there is no relevant cell type, and we decided to consider regions with replication direction conserved across tissue types, requiring that all seven tissues have the same sign of the replication timing 'derivative' and that in at least half of the tissues (four out of seven) the value of the 'derivative' exceeded the 40% threshold. We also used replication timing data obtained from the NHEK cell line to predict the preferential fork direction in the analysis of XR-seq and Damage-seq data and our experimental dataset (matching the tissue but not the exact cell type).
For each mutation type, we calculated R-asymmetry as the ratio of mutation density on the lagging strand to mutation density on the leading strand. Samples with fewer than 100 mutations on each strand were excluded from the analysis to reduce sampling noise.
XPC knockouts have a distinct mutational spectrum that is dominated by TpCpT> TpTpT mutations (underline denotes mutated nucleotide; Supplementary  Fig. 9 ), and we restrict our test to this mutation type. Supplementary Fig. 5 focuses on the magnitude of the effect in each tumor rather than on the presence of the effect. We therefore excluded samples with fewer than 500 mutations on each strand. The relaxation of the threshold to 100 mutations does not change the conclusions (data not shown).
To exclude the impact of T-asymmetry on the R-asymmetry estimation, we restricted the analysis of R-asymmetry to intergenic regions.
T-asymmetry.
For each mutation type, we calculated T-asymmetry as a ratio of mutation density on the transcribed strand to mutation density on the nontranscribed strand. Gene annotations and transcription direction were determined according to the knownGene track of the UCSC genome browser. Tumors with T-asymmetry > 1.2 (for any of the six major mutation classes) were considered to have a high level of T-asymmetry. Even with this lenient criterion, only four cancer types (melanoma, LUAD, LUSC and liver cancer) had more than 20 tumor samples in this category. To order the genes by their expression levels, we selected the most relevant tissues from the Genotype-Tissue Expression (GTEx) Program 49 : testis for SNPs from gnomAD, sun-exposed skin for melanoma, liver for liver cancer and lung for lung cancers.
Exclusion of replica B2 at 48 h from Damage-seq. T-asymmetry and the difference between genic and non-genic regions are the main results of the Damage-seq experiments 32 that support the utility of the data for the genomewide analysis of bulky DNA damage and repair by the NER system. Thus, for quality control of the Damage-seq data, we calculated T-asymmetry and the ratio of reads in intergenic and genic regions separately for all replicas. T-asymmetry and the ratio of reads in intergenic and genic regions were normalized using the corresponding values for naked DNA. We found that the replicates were generally concordant at each time point, with the exception of the 48 h point, where we found substantial T-asymmetry and prevalence of mutations in intergenic regions in replica A but essentially no signal in replica B2 ( Supplementary Fig. 10 ). At other time points, we observed a clear, time-dependent increase in T-asymmetry and a decrease in the fraction of damages in genic regions, as expected. Based on these observations, we argue that the absence of the signal in replica B2 at 48 h is an artifact. Therefore, this data point was excluded. As shown in Supplementary  Fig. 10c , this replica is also a clear outlier in the analysis of R-asymmetry.
Estimate of the proportion of mutations arising due to DNA damage in human cancers and the germline.
To conservatively estimate the proportion of damageinduced mutations, we capitalized on the statistical signal of T-asymmetry that is associated with DNA damage. The T-asymmetry introduced by co-transcriptional processes cannot be a consequence of replication infidelity. Therefore, mutations responsible for the T-asymmetry must be damage induced. Since transcribed and non-transcribed regions can have different susceptibilities to DNA damage, we conservatively compared the levels of mutations between the transcribed strand and immediately adjacent flanking sequences rather than between transcribed and non-transcribed strands:
where μ _ transcribed strand is the mutation density on the transcribed strand and μ intergenic is the mutation density in flanking intergenic regions. on 3 coverslips at an average of 20 cells per region) of the fraction of cells that incorporated EdU. Cells were stained with the EdU detection kit (Click-iT EdU Imaging Kit, Thermo Fisher Scientific) to count divided cells and stained with Hoechst to count the total number of cells.
In each sample, we measured the proliferation rate via EdU incorporation during the first 24 h (adding EdU 5 min after ultraviolet irradiation and staining cells after 24 h) and the second 24 h (adding EdU after 24 h and staining the cells after 48 h). Examples of the EdU staining are shown in Supplementary Figs. 11 and 12. Adding roscovitine to the medium decreases proliferation rate by twofold to threefold compared with the control population ( Supplementary Fig. 13 ). Ultraviolet irradiation itself decreased the proliferation rate by fivefold, followed by a substantial recovery on day two. Combination of the ultraviolet irradiation and roscovitine almost completely halted cell proliferation both on day one and day two. Moreover, we observed that during the colony selection, cells treated with roscovitine grew more slowly than non-treated cells.
Mutation calling. To obtain the set of mutations from sequenced reads, we performed the following steps. First, we trimmed reads with TrimGalore-0.4.5 in paired mode; then we mapped reads with bwa-0.7.12 according to GATK best practices; then we called mutations from binary alignment map files with MuTect2 using the control colony (no roscovitine treatment or ultraviolet irradiation) as 'normal' and other colonies (treated with roscovitine, ultraviolet irradiation or both) as 'tumor' . Finally, we filtered out all the mutations observed in more than one colony. Mutation spectra for all replicates are shown in Supplementary Fig. 14 
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